Nanotechnologie Nachrichten

Zeit	Aktuelle Nachrichten Sprache: Alle DE EN	Leser	Medien
13:50	Zentek Ltd.: Zentek Files Technical Report for the Albany Graphite PEA: US$3.85 Billion After-Tax NPV at a 5% Discount Rate, 27.4% After-Tax IRR, on an Acid-Free Route to Ultra-High-Purity Graphite	338	Newsfile	Initial capital of US$817 million, after-tax payback of 4.4 years and a 30-year production period. Micon recommends advancing Albany to a Pre-Feasibility Study.Filed on SEDAR+ on September 24, 2026... ► Artikel lesen
13:02	Rise Nano Optics Ltd.: Rise Nano Optics to Sponsor INVISION MATCH! 2026, Connecting SpectraGuard with Leading Independent Eye Care Practices	165	Newsfile	Company to participate in curated one-on-one meetings with leading independent optometry practice owners as it expands U.S. commercialization of SpectraGuardVancouver, British Columbia--(Newsfile Corp.... ► Artikel lesen
10:26	Formycon-Aktie: Warum FYB206 jetzt Aufsehen erregt	7	Maximilian Berger
10:09	GOMSPACE GROUP AB: GomSpace joins ESA-funded study for future Arctic satellite constellation supporting secure maritime communication	5	Cision News
07:29	Riber Reports Improved Results For The First Half Of 2026	10	Euronext
05:31	2 von 3 Menschen ohne benötigte Brille: Warum die WHO den Milliardenmarkt für gutes Sehen verändern will - und wo Rise Nano Optics ansetzt		Small- & Micro Cap Investment
02:22	NEXSEN LIMITED: Suspension from Quotation	1	ASX
02:21	NEXSEN LIMITED: Clear pathway defined to optimise StrepSure	1	ASX
01:13	ANTEOTECH LTD: Notification regarding unquoted securities - ADO	3	ASX
Mi	Alchemy Labs Inc: Alchemy Labs expands ExoShield kits to 40 vehicle models	2	Stockwatch
Mi	Fabric.AI Files Two Patent Applications Covering Fiber-Coupled and Connector-Free MicroLED Optical Interconnect, Developed with Kopin	7	GlobeNewswire (USA)
Mi	Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox Has Begun in DRC, Announces NanoViricides	670	ACCESS Newswire	SHELTON, CT / ACCESS Newswire / September 23, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that the Phase II Clinical Trial of the Company's Novel Broad-Spectrum Antiviral... ► Artikel lesen
Mi	Alchemy Labs Inc.: Alchemy Expands ExoShield(R) ULTRA Pro Portfolio to 40 Vehicle Models, Adding Major GM Pickup and SUV Platforms	260	Newsfile	Kitchener, Ontario--(Newsfile Corp. - September 23, 2026) - Alchemy Labs Inc. (TSXV: ALCH) ("Alchemy" or the "Company"), a Canadian nanotechnology company developing advanced protective solutions for... ► Artikel lesen
Mi	ANTEOTECH LTD: FY26 Results Investor Webinar	2	ASX
Di	$1000 Invested In Onto Innovation 10 Years Ago Would Be Worth This Much Today	2	Benzinga.com
Di	Formycon: FYB206-Entwicklungsansatz in Fachjournal	840	4investors	Formycon meldet die Veröffentlichung der wissenschaftlichen und regulatorischen Grundlagen des klinischen Entwicklungsprogramms für den Biosimilar-Kandidaten FYB206 im Fachjournal BioDrugs. Im Mittelpunkt... ► Artikel lesen
Di	Formycon setzt Maßstäbe in der Biosimilar-Entwicklung	15	fixed-income.org
Di	XFRA WG0: AUSSETZUNG/SUSPENSION	246	Xetra Newsboard	DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNEXSEN O.N. WG0... ► Artikel lesen
Di	Quantum Base Hldgs - Management Change	-	RNS
Di	Formycon: FYB206 zeigt neuen Weg für Biosimilars	616	BondGuide	Formycon hat die wissenschaftlichen Grundlagen seines Entwicklungsprogramms für FYB206 im peer-reviewten Fachjournal BioDrugs veröffentlicht. Der Artikel beschreibt am Beispiel des Pembrolizumab-Biosimilars... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Sprache: Alle DE EN

Leser

Medien

13:50

Zentek Ltd.: Zentek Files Technical Report for the Albany Graphite PEA: US$3.85 Billion After-Tax NPV at a 5% Discount Rate, 27.4% After-Tax IRR, on an Acid-Free Route to Ultra-High-Purity Graphite

338

Newsfile

Initial capital of US$817 million, after-tax payback of 4.4 years and a 30-year production period. Micon recommends advancing Albany to a Pre-Feasibility Study.Filed on SEDAR+ on September 24, 2026...
► Artikel lesen

13:02

Rise Nano Optics Ltd.: Rise Nano Optics to Sponsor INVISION MATCH! 2026, Connecting SpectraGuard with Leading Independent Eye Care Practices

165

Newsfile

Company to participate in curated one-on-one meetings with leading independent optometry practice owners as it expands U.S. commercialization of SpectraGuardVancouver, British Columbia--(Newsfile Corp....
► Artikel lesen